Piper Sandler Downgrades POINT Biopharma Global Inc. (PNT) to Neutral

October 24, 2023 12:23 AM EDT Send to a Friend
Piper Sandler analyst Edward Tenthoff downgraded POINT Biopharma Global Inc. (NASDAQ: PNT) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login